Giraud A, Ataman-Onal Y, Battail N, Piga N, Brand D, Mandrand B, Verrier B
Laboratoire de rétrovirologie, Unité Mixte CNRS-bio Mérieux UMR103, Ecole Normale Supérieure de Lyon, France.
J Virol Methods. 1999 Apr;79(1):75-84. doi: 10.1016/s0166-0934(99)00009-9.
The Semliki Forest virus (SFV) vector system is a new approach for in vivo expression of heterologous proteins and can also be used to generate specific immune responses in animal models. HIV-1 envelope glycoprotein produced using the SFV expression system is correctly folded, cleaved, transported to the cell surface and exhibits functional activity. We evaluated a recombinant Semliki Forest virus naked RNA-based immunization protocol for generation of monoclonal antibodies against the HIV-1 envelope glycoprotein. In vitro-transcribed RNA encoding for the SFV replicase complex and Env protein of HIV-1 (HXB2 strain) was injected intramuscularly to mice. This approach elicited an Env-specific antibody response in four mice out of five and a monoclonal antibody, 12H2, directed against gp41 was produced. Our results show that recombinant SFV RNA immunization can potentially be used as a quick and direct method to produce monoclonal antibodies, with the particular advantage that vectored RNA, rather than purified antigen, delivers a complex oligomer produced correctly.
塞姆利基森林病毒(SFV)载体系统是一种在体内表达异源蛋白的新方法,也可用于在动物模型中产生特异性免疫反应。使用SFV表达系统产生的HIV-1包膜糖蛋白能够正确折叠、切割、转运至细胞表面并表现出功能活性。我们评估了一种基于重组塞姆利基森林病毒裸RNA的免疫方案,用于生成针对HIV-1包膜糖蛋白的单克隆抗体。将编码SFV复制酶复合物和HIV-1(HXB2株)Env蛋白的体外转录RNA肌肉注射到小鼠体内。该方法在五只小鼠中的四只中引发了Env特异性抗体反应,并产生了一种针对gp41的单克隆抗体12H2。我们的结果表明,重组SFV RNA免疫有可能用作生产单克隆抗体的快速直接方法,其特别优势在于载体RNA而非纯化抗原传递正确产生的复杂寡聚体。